OmniAb, Inc. SEC filings OABI
OmniAb, Inc. has 387 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Sep 12, 2025 | — |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| POS AM | Filing | Dec 8, 2023 | — |
| S-3 | Shelf registration | Dec 8, 2023 | — |
| 424B3 | Prospectus | Nov 13, 2023 | — |
| 424B3 | Prospectus | Nov 2, 2023 | — |
| 424B3 | Prospectus | Aug 10, 2023 | — |
| POS AM | Filing | May 5, 2023 | — |
| 424B3 | Prospectus | Mar 31, 2023 | — |
| 424B3 | Prospectus | Feb 10, 2023 | — |
| S-1/A | Amended registration statement | Feb 7, 2023 | — |
| S-1/A | Amended registration statement | Jan 5, 2023 | — |
| S-8 | Employee stock plan registration | Jan 3, 2023 | — |
| S-1 | Registration statement | Nov 30, 2022 | — |
| 424B3 | Prospectus | Sep 30, 2022 | — |
| S-4/A | Filing | Sep 27, 2022 | — |
| S-4/A | Filing | Sep 13, 2022 | — |
| S-4/A | Form s-4/a | Aug 22, 2022 | — |
| S-4/A | Filing | Jul 26, 2022 | — |
| S-4/A | Form s-4/a | Jun 13, 2022 | — |
| S-4 | Registration for a merger or exchange | Apr 28, 2022 | — |
| 424B4 | Prospectus | Aug 11, 2021 | — |
| S-1/A | Amended registration statement | Jul 28, 2021 | — |
| S-1 | Registration statement | Jun 17, 2021 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- OABI (Nasdaq), OABIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1846253
- Former names
- Avista Public Acquisition Corp. II (until Nov 1, 2022)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.